1. Home
  2. MIST vs KOSS Comparison

MIST vs KOSS Comparison

Compare MIST & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • KOSS
  • Stock Information
  • Founded
  • MIST 2003
  • KOSS 1953
  • Country
  • MIST Canada
  • KOSS United States
  • Employees
  • MIST N/A
  • KOSS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • MIST Health Care
  • KOSS Consumer Staples
  • Exchange
  • MIST Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • MIST 164.9M
  • KOSS 53.6M
  • IPO Year
  • MIST N/A
  • KOSS N/A
  • Fundamental
  • Price
  • MIST $2.03
  • KOSS $5.49
  • Analyst Decision
  • MIST Strong Buy
  • KOSS
  • Analyst Count
  • MIST 3
  • KOSS 0
  • Target Price
  • MIST $6.33
  • KOSS N/A
  • AVG Volume (30 Days)
  • MIST 1.3M
  • KOSS 49.7K
  • Earning Date
  • MIST 11-11-2025
  • KOSS 10-28-2025
  • Dividend Yield
  • MIST N/A
  • KOSS N/A
  • EPS Growth
  • MIST N/A
  • KOSS N/A
  • EPS
  • MIST N/A
  • KOSS N/A
  • Revenue
  • MIST N/A
  • KOSS $12,624,170.00
  • Revenue This Year
  • MIST N/A
  • KOSS N/A
  • Revenue Next Year
  • MIST N/A
  • KOSS N/A
  • P/E Ratio
  • MIST N/A
  • KOSS N/A
  • Revenue Growth
  • MIST N/A
  • KOSS 2.93
  • 52 Week Low
  • MIST $0.63
  • KOSS $4.00
  • 52 Week High
  • MIST $2.75
  • KOSS $8.59
  • Technical
  • Relative Strength Index (RSI)
  • MIST 54.27
  • KOSS 47.28
  • Support Level
  • MIST $1.92
  • KOSS $4.72
  • Resistance Level
  • MIST $2.14
  • KOSS $5.70
  • Average True Range (ATR)
  • MIST 0.12
  • KOSS 0.25
  • MACD
  • MIST -0.02
  • KOSS 0.03
  • Stochastic Oscillator
  • MIST 30.67
  • KOSS 46.10

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: